120. Impact of a Molecular Point-of-care ‘test and Treat’ Strategy for Influenza in Hospitalised adults: A Multi-centre, Randomised Controlled Trial (FluPOC)

Ítems similars

• Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol
  per: Beard, Kate, et al.
  Publicat: (2019)
• 1717. The Impact of Routine Molecular Point-of-care Testing for Gastrointestinal Pathogens in Adults Hospitalized With Suspected Gastroenteritis: Results of a Pragmatic Randomized Controlled Trial (GastroPOC)
  per: Malachira, Ahalya, et al.
  Publicat: (2018)
• Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial
  per: Brendish, Nathan J, et al.
  Publicat: (2017)
• Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)
  per: Brendish, Nathan J., et al.
  Publicat: (2017)
• Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19
  per: Clark, Tristan W., et al.
  Publicat: (2020)